3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasms
6
Leukemia
3
Leukemia, Myeloid, Acute
2
Disease
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Sexually Transmitted Diseases
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oropharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Infertility
1
Hypergammaglobulinemia
1
Hospitalism
1
Hematological Cancer
1
Hematologic Diseases
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Gestational Trophoblastic Tumours
1
Genetic Predisposition to Disease
1
Gastrointestinal Stromal Tumors
1
Exanthema
1
Dermatitis, Seborrheic
1
Depression
1
Interventions
Ipilimumab
3
Triamcinolone Acetonide
2
Ranibizumab
2
Nivolumab
2
Amplified Fragment Length Polymorphism Analysis
2
treosulfan
1
salicylhydroxamic acid
1
aldesleukin
1
Ultrasonography
1
Tramadol
1
Temozolomide
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Rose Bengal
1
Radiosurgery
1
Physical Examination
1
Pharmacogenomic Testing
1
Interviews as Topic
1
Immunotherapy
1
Ibuprofen
1
Gemcitabine
1
Eye Enucleation
1
Cyclophosphamide
1
Cisplatin
1
Chemotherapy, Adjuvant
1
CTLA-4 Antigen
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uveal Melanoma
×
Interviews as Topic
×
Clear all
NCT06073548
2023-10-10
SALOME Quali
Institut Curie
Unknown
250 enrolled